Publications for Andrew Spillane
Publications for Andrew Spillane
2016
Haydu, L., Stollman, L., Scolyer, R., Spillane,
A., Quinn, M., Saw, R., Shannon, K., Stretch, J.,
Bonenkamp, J., Thompson, J. (2016). Minimum
Safe Pathologic Excision Margins for Primary
Cutaneous Melanomas (1-2 mm in Thickness):
Analysis of 2131 Patients Treated at a Single
Center. Annals of Surgical Oncology, 23(4),
1071-1081. <a
href="http://dx.doi.org/10.1245/s10434-015-457
5-3">[More Information]</a>
Brennan, M., Butow, P., Spillane, A., Boyle, F.
(2016). Patient-reported quality of life, unmet
needs and care coordination outcomes: Moving
toward targeted breast cancer survivorship care
planning. Asia-Pacific Journal of Clinical
Oncology, 12(2), e323-e331. <a
href="http://dx.doi.org/10.1111/ajco.12254">[M
ore Information]</a>
Oh, D., Flitcroft, K., Brennan, M., Spillane, A.
(2016). Patterns and outcomes of breast
reconstruction in older women - A systematic
review of the literature. European Journal of
Surgical Oncology, 42(5), 604-615. <a
href="http://dx.doi.org/10.1016/j.ejso.2016.02.01
0">[More Information]</a>
MacKenzie Ross, A., Haydu, L., Quinn, M.,
Saw, R., Shannon, K., Spillane, A., Stretch, J.,
Scolyer, R., Thompson, J. (2016). The
Association Between Excision Margins and
Local Recurrence in 11,290 Thin (T1) Primary
Cutaneous Melanomas: A Case-Control Study.
Annals of Surgical Oncology, 23(4), 1082-1089.
<a
href="http://dx.doi.org/10.1245/s10434-015-494
2-0">[More Information]</a>
Lyle, M., Haydu, L., Menzies, A., Thompson, J.,
Saw, R., Spillane, A., Kefford, R., Mann, G.,
Cooper, W., Yu, B., Scolyer, R., O'Toole, S.,
Long, G. (2016). The molecular profile of
metastatic melanoma in Australia. Pathology,
48(2), 188-193. <a
href="http://dx.doi.org/10.1016/j.pathol.2015.12.
008">[More Information]</a>
Spillane, A. (2016). What is new in the surgical
management and prevention of breast cancer?
Medical Journal of Australia, 204(8),
311-3.14E+03. <a
href="http://dx.doi.org/10.5694/mja16.00002">[
More Information]</a>
2015
Brennan, M., Boyle, F., Butow, P., Spillane, A.
(2015). Evaluation of a survivorship care plan:
long-term use, care coordination and quality of
life in breast cancer survivors. Breast Cancer
Management, 4(3), 145-157. <a
href="http://dx.doi.org/10.2217/bmt.15.5">[Mor
e Information]</a>
Read, R., Haydu, L., Saw, R., Quinn, M.,
Shannon, K., Spillane, A., Stretch, J., Scolyer,
R., Thompson, J. (2015). In-transit Melanoma
Metastases: Incidence, Prognosis, and the Role
of Lymphadenectomy. Annals of Surgical
Oncology, 22(2), 475-481. <a
href="http://dx.doi.org/10.1245/s10434-014-410
0-0">[More Information]</a>
Chong, C., Walters, D., De Silva, P., Taylor, C.,
Spillane, A., Kollias, J., Pyke, C., Campbell, I.,
Maddern, G. (2015). Initial axillary surgery:
Results from the BreastSurgANZ Quality Audit.
ANZ Journal of Surgery, 85(10), 777-782. <a
href="http://dx.doi.org/10.1111/ans.12455">[Mo
re Information]</a>
Spillane, A. (2015). Localizing non-palpable
breast lesions: The subtleties of selecting the
right method. ANZ Journal of Surgery, 85(7-8),
497-498. <a
href="http://dx.doi.org/10.1111/ans.13146">[Mo
re Information]</a>
Read, R., Pasquali, S., Haydu, L., Thompson, J.,
Stretch, J., Saw, R., Quinn, M., Shannon, K.,
Spillane, A. (2015). Quality assurance in
melanoma surgery: The evolving experience at a
large tertiary referral centre. European Journal
of Surgical Oncology, 41(7), 830-836. <a
href="http://dx.doi.org/10.1016/j.ejso.2014.12.00
3">[More Information]</a>
Spillane, A., Read, R., Thompson, J. (2015).
Sentinel node biopsy should be thestandard of
care for patients with intermediate and thick
melanomas. Australian Family Physician, 44(8),
604-606.
Read, R., Flitcroft, K., Snook, K., Boyle, F.,
Spillane, A. (2015). Utility of neoadjuvant
chemotherapy in the treatment of operable breast
cancer. ANZ Journal of Surgery, 85(5), 315-320.
<a
href="http://dx.doi.org/10.1111/ans.12975">[Mo
re Information]</a>
2014
Saw, R., Armstrong, B., Mason, R., Morton, R.,
Shannon, K., Spillane, A., Stretch, J., Thompson,
J. (2014). Adjuvant therapy with high dose
vitamin D following primary treatment of
melanoma at high risk of recurrence: a placebo
controlled randomised phase II trial (ANZMTG
02.09 Mel-D). BMC Cancer, 14, 1-10. <a
href="http://dx.doi.org/10.1186/1471-2407-14-7
80">[More Information]</a>
Pasquali, S., Spillane, A. (2014). Contemporary
controversies and perspectives in the staging and
treatment of patients with lymph node metastasis
Publications for Andrew Spillane
from melanoma, especially with regards positive
sentinel lymph node biopsy. Cancer Treatment
Reviews, 40(8), 893-899. <a
href="http://dx.doi.org/10.1016/j.ctrv.2014.06.00
8">[More Information]</a>
Wong, A., Snook, K., Brennan, M., Flitcroft, K.,
Tucker, M., Hiercz, D., Spillane, A. (2014).
Increasing breast reconstruction rates by offering
more women a choice. ANZ Journal of Surgery,
84(1-2), 31-36. <a
href="http://dx.doi.org/10.1111/ans.12471">[Mo
re Information]</a>
Snook, K., Spillane, A. (2014). Intraoperative
molecular sentinel node analysis: the way of the
future or great technology with limited
indication? ANZ Journal of Surgery, 84(10),
699-700. <a
href="http://dx.doi.org/10.1111/ans.12714">[Mo
re Information]</a>
Flitcroft, K., Spillane, A., Read, R. (2014). Lack
of appropriate imaging before breast
augmentation can have serious patient
consequences. Medical Journal of Australia,
200(4), 198-199. <a
href="http://dx.doi.org/10.5694/mja13.11217">[
More Information]</a>
van der Ploeg, A., Haydu, L., Spillane, A.,
Scolyer, R., Quinn, M., Saw, R., Shannon, K.,
Stretch, J., Thompson, J. (2014). Melanoma
patients with an unknown primary tumor site
have a better outcome than those with a known
primary following therapeutic lymph node
dissection for macroscopic (clinically palpable)
nodal disease. Annals of Surgical Oncology,
21(9), 3108-3116. <a
href="http://dx.doi.org/10.1245/s10434-014-367
9-5">[More Information]</a>
van der Ploeg, A., Haydu, L., Spillane, A.,
Quinn, M., Saw, R., Shannon, K., Stretch, J.,
Uren, R., Scolyer, R., Thompson, J. (2014).
Outcome Following Sentinel Node Biopsy Plus
Wide Local Excision Versus Wide Local
Excision Only for Primary Cutaneous
Melanoma: Analysis of 5840 Patients Treated at
a Single Institution. Annals of Surgery, 260(1),
149-157. <a
href="http://dx.doi.org/10.1097/SLA.000000000
0000500">[More Information]</a>
Lymph Node Tumor Burden. Annals of Surgical
Oncology, 21(1), 292-299. <a
href="http://dx.doi.org/10.1245/s10434-013-325
3-6">[More Information]</a>
Brennan, M., Spillane, A., Flitcroft, K., Snook,
K., Wong, A. (2014). Platinum multidisciplinary
breast cancer care or platinum breast
reconstruction? ANZ Journal of Surgery, 84(9),
604-605.
Huismans, A., Haydu, L., Shannon, K., Quinn,
M., Saw, R., Spillane, A., Stretch, J., Thompson,
J. (2014). Primary Melanoma Location on the
Scalp is an Important Risk Factor for Brain
Metastasis: A Study of 1,687 Patients with
Cutaneous Head and Neck Melanomas. Annals
of Surgical Oncology, 21(12), 3985-3991. <a
href="http://dx.doi.org/10.1245/s10434-014-382
9-9">[More Information]</a>
Brennan, M., Gormally, J., Butow, P., Boyle, F.,
Spillane, A. (2014). Survivorship care plans in
cancer: a systematic review of care plan
outcomes. British Journal of Cancer, 111(10),
1899-1908. <a
href="http://dx.doi.org/10.1038/bjc.2014.505">[
More Information]</a>
Lamboo, L., Haydu, L., Scolyer, R., Quinn, M.,
Saw, R., Shannon, K., Spillane, A., Stretch, J.,
Bonenkamp, J., Thompson, J. (2014). The
optimum excision margin and regional node
management for primary cutaneous T3
melanomas (2-4 mm in thickness): A
retrospective study of 1587 patients treated at a
single center. Annals of Surgery, 260(6),
1095-1102. <a
href="http://dx.doi.org/10.1097/SLA.000000000
0000792">[More Information]</a>
2013
Soon, P., Kim, E., Pon, C., Gill, A., Moore, K.,
Spillane, A., Benn, D., Baxter, R. (2013). Breast
cancer-associated fibroblasts induce
epithelial-to-mesenchymal transition in breast
cancer cells. Endocrine-Related Cancer, 20(1),
1-12. <a
href="http://dx.doi.org/10.1530/ERC-12-0227">[
More Information]</a>
Wong, A., Spillane, A. (2014). Patent Blue V
dye anaphylaxis: experience of Australian and
New Zealand surgeons. ANZ Journal of Surgery,
84(1-2), 37-41. <a
href="http://dx.doi.org/10.1111/j.1445-2197.201
2.06277.x">[More Information]</a>
Noushi, F., Spillane, A., Uren, R., Cooper, R.,
Allwright, S., Snook, K., Gillett, D., Pearce, A.,
Gebski, V. (2013). High discordance rates
between sub-areolar and peri-tumoural breast
lymphoscintigraphy. European Journal of
Surgical Oncology, 39(10), 1053-1060. <a
href="http://dx.doi.org/10.1016/j.ejso.2013.06.00
6">[More Information]</a>
Spillane, A., Pasquali, S., Haydu, L., Thompson,
J. (2014). Patterns of Recurrence and Survival
After Lymphadenectomy in Melanoma Patients:
Clarifying the Effects of Timing of Surgery and
Chong, C., Walters, D., De Silva, P., Taylor, C.,
Spillane, A., Kollias, J., Pyke, C., Campbell, I.,
Maddern, G. (2013). Subsequent axillary surgery
after sentinel lymph node biopsy: Results from
Publications for Andrew Spillane
the BreastSurgANZ Quality Audit 2006-2010.
The Breast, 22(6), 1215-1219. <a
href="http://dx.doi.org/10.1016/j.breast.2013.09.
005">[More Information]</a>
Pasquali, S., Haydu, L., Scolyer, R., Winstanley,
J., Spillane, A., Quinn, M., Saw, R., Shannon,
K., Stretch, J., Thompson, J. (2013). The
Importance of Adequate Primary Tumor
Excision Margins and Sentinel Node Biopsy in
Achieving Optimal Locoregional Control for
Patients With Thick Primary Melanomas. Annals
of Surgery, 258(1), 152-157. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
28421e1">[More Information]</a>
Spillane, A. (2013). Training breast surgeons in
Australia and New Zealand. ANZ Journal of
Surgery, 83(9), 597-598. <a
href="http://dx.doi.org/10.1111/ans.12322">[Mo
re Information]</a>
Brennan, M., Spillane, A. (2013). Uptake and
predictors of post-mastectomy reconstruction in
women with breast malignancy - Systematic
review. European Journal of Surgical Oncology,
39(6), 527-541. <a
href="http://dx.doi.org/10.1016/j.ejso.2013.02.02
1">[More Information]</a>
Spillane, A. (2013). Why the results of the
American College of Surgeons Oncology Group
Z0011 Trial are so important. ANZ Journal of
Surgery, 83, 893-893. <a
href="http://dx.doi.org/10.1111/ans.12385">[Mo
re Information]</a>
2012
Murali, R., Haydu, L., Long, G., Quinn, M.,
Saw, R., Shannon, K., Spillane, A., Stretch, J.,
Kefford, R., Thompson, J., Scolyer, R. (2012).
Clinical and Pathologic Factors Associated with
Distant Metastasis and Survival in Patients with
Thin Primary Cutaneous Melanoma. Annals of
Surgical Oncology, 19(6), 1782-1789. <a
href="http://dx.doi.org/10.1245/s10434-012-226
5-y">[More Information]</a>
Spillane, A., Haydu, L., Lee, N., Uren, R.,
Stretch, J., Shannon, K., Quinn, M., Saw, R.,
McCarthy, W., Thompson, J. (2012). Evaluation
of Incomplete Sentinel Node Biopsy Procedures
and Sentinel Node Positivity Rates as Surgical
Quality-Assurance Parameters in Melanoma
Patients. Annals of Surgical Oncology, 19(12),
3919-3925. <a
href="http://dx.doi.org/10.1245/s10434-012-242
7-y">[More Information]</a>
Noushi, F., Spillane, A., Uren, R. (2012). In
Regard to Hindie et al. International Journal of
Radiation: Oncology - Biology - Physics, 84(2),
302-302. <a
href="http://dx.doi.org/10.1016/j.ijrobp.2012.02.
011">[More Information]</a>
Lee, N., Spillane, A., Pang, T., Haydu, L., Uren,
R. (2012). Incomplete Sentinel Node Biopsy Is
Not Clearly Related to Survival or Regional
Recurrence in Cutaneous Melanoma Patients.
Annals of Surgical Oncology, 19(1), 280-286. <a
href="http://dx.doi.org/10.1245/s10434-011-187
2-3">[More Information]</a>
Sung-In Jang, H., Spillane, A., Boyle, F.,
Fogarty, G. (2012). Radiotherapy can cause
haemostasis in bleeding skin malignancies. Case
Reports in Medicine, 2012, 168681- 1-1686814. <a
href="http://dx.doi.org/10.1155/2012/168681">[
More Information]</a>
Murali, R., Haydu, L., Quinn, M., Saw, R.,
Shannon, K., Spillane, A., Stretch, J., Thompson,
J., Scolyer, R. (2012). Sentinel Lymph Node
Biopsy in Patients With Thin Primary Cutaneous
Melanoma. Annals of Surgery, 255(1), 128-133.
<a
href="http://dx.doi.org/10.1097/SLA.0b013e318
2306c72">[More Information]</a>
Spillane, A., Thompson, J. (2012). Sentinel node
biopsy for breast cancer: then and now. ANZ
Journal of Surgery, 82(7/8), 481-483. <a
href="http://dx.doi.org/10.1111/j.1445-2197.201
2.06135.x">[More Information]</a>
Uren, R., Howman-Giles, R., Chung, D.,
Spillane, A., Noushi, F., Gillett, D., Gluch, L.,
Mak, C., West, R., Briody, J., Carmalt, H.
(2012). SPECT/CT scans allow precise
anatomical location of sentinel lymph nodes in
breast cancer and redefine lymphatic drainage
from the breast to the axilla. The Breast, 21(4),
480-486. <a
href="http://dx.doi.org/10.1016/j.breast.2011.11.
007">[More Information]</a>
Pasquali, S., Spillane, A., de Wilt, J., McCaffery,
K., Rossi, C., Quinn, M., Saw, R., Shannon, K.,
Stretch, J., Thompson, J. (2012). Surgeons'
Opinions on Lymphadenectomy in Melanoma
Patients with Positive Sentinel Nodes: A
Worldwide Web-Based Survey. Annals of
Surgical Oncology, 19(13), 4322-4329. <a
href="http://dx.doi.org/10.1245/s10434-012-248
3-3">[More Information]</a>
Martin, R., Shannon, K., Quinn, M., Saw, R.,
Spillane, A., Stretch, J., Colman, M., Gao, K.,
Thompson, J. (2012). The Management of
Cervical Lymph Nodes in Patients with
Cutaneous Melanoma. Annals of Surgical
Oncology, 19(12), 3926-3932. <a
href="http://dx.doi.org/10.1245/s10434-012-237
4-7">[More Information]</a>
2011
Spillane, A., Tucker, M., Pasquali, S. (2011). A
Publications for Andrew Spillane
Pilot Study Reporting Outcomes for Melanoma
Patients of a Minimal Access Ilio-inguinal
Dissection Technique Based on Two Incisions.
Annals of Surgical Oncology, 18(4), 970-976. <a
href="http://dx.doi.org/10.1245/s10434-010-145
5-8">[More Information]</a>
European Journal of Surgical Oncology, 37(5),
454-455. <a
href="http://dx.doi.org/10.1016/j.ejso.2011.01.02
2">[More Information]</a>
Spillane, A., Brennan, M. (2011). Accuracy of
sentinel lymph node biopsy in large and
multifocal/multicentric breast carcinoma -
Crosbie, W., Kilbreath, S., Dylke, E., Refshauge,
K., Nicholson, L., Beith, J., Spillane, A., White,
K. (2010). Effects of Mastectomy on Shoulder
and Spinal Kinematics During Bilateral
Upper-Limb Movement. Physical Therapy,
90(5), 679-692. <a
href="http://dx.doi.org/10.2522/ptj.20090104">[
More Information]</a>
A systematic review. European Journal of
Surgical Oncology, 37(5), 371-385. <a
href="http://dx.doi.org/10.1016/j.ejso.2011.01.01
1">[More Information]</a>
Brennan, M., Butow, P., Spillane, A., Marven,
M., Boyle, F. (2011). Follow up after breast
cancer - views of Australian women. Australian
Family Physician, 40(5), 311-316. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21597552">[More Information]</a>
Noushi, F., Spillane, A., Uren, R., Gebski, V.
(2011). Internal Mammary Lymph Node
Metastasis in Breast Cancer: Predictive Models
to Assist with Prognostic Influence. The Breast,
20(3), 278-283. <a
href="http://dx.doi.org/10.1016/j.breast.2010.12.
008">[More Information]</a>
Spillane, A., Cheung, B., Winstanley, J.,
Thompson, J. (2011). Lymph Node Ratio
Provides Prognostic Information in Addition to
American Joint Committee on Cancer N Stage in
Patients With Melanoma, Even If Quality of
Surgery Is Standardized. Annals of Surgery,
253(1), 109-115. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
1f9b8b6">[More Information]</a>
Spillane, A., Haydu, L., McMillan, W., Stretch,
J., Thompson, J. (2011). Quality Assurance
Parameters and Predictors of Outcome for
Ilioinguinal and Inguinal Dissection in a
Contemporary Melanoma Patient Population.
Annals of Surgical Oncology, 18(9), 2521-2528.
<a
href="http://dx.doi.org/10.1245/s10434-011-175
5-7">[More Information]</a>
Brennan, M., Butow, P., Marven, M., Spillane,
A., Boyle, F. (2011). Survivorship care after
breast cancer treatment - Experiences and
preferences of Australian women. The Breast,
20(3), 271-277. <a
href="http://dx.doi.org/10.1016/j.breast.2010.12.
006">[More Information]</a>
Lee, N., Spillane, A. (2011). Underpowered
conclusions can be potentially misleading with
regards to the ratio of number of
lymphoscintigraphy identified and surgically
excised sentinel nodes in melanoma patients.
2010
Zardawi, S., Zardawi, I., McNeil, C., Millar, E.,
McLeod, D., Morey, A., Crea, P., Murphy, N.,
Pinese, M., Lopez-Knowles, E., Hamilton, A.,
Spillane, A., Lee, C., et al (2010). High Notch1
protein expression is an early event in breast
cancer development and is associated with the
HER-2 molecular subtype. Histopathology,
56(3), 286-296. <a
href="http://dx.doi.org/10.1111/j.1365-2559.200
9.03475.x">[More Information]</a>
Noushi, F., Spillane, A., Uren, R., Gebski, V.
(2010). Internal mammary node metastasis in
breast cancer: Predictive models to determine
status & management algorithms. European
Journal of Surgical Oncology, 36(1), 16-22. <a
href="http://dx.doi.org/10.1016/j.ejso.2009.09.00
6">[More Information]</a>
Karim, R., Gerega, S., Yang, J., Spillane, A.,
Carmalt, H., Scolyer, R., Lee, C. (2010). p16 and
pRb immunohistochemical expression increases
with increasing tumour grade in mammary
phyllodes tumours. Histopathology, 56(7),
868-875. <a
href="http://dx.doi.org/10.1111/j.1365-2559.201
0.03562.x">[More Information]</a>
Brennan, M., Butow, P., Spillane, A., Boyle, F.
(2010). Survivorship care after breast cancer:
Follow-up practices of Australian health
professionals and attitudes to a survivorship care
plan. Asia-Pacific Journal of Clinical Oncology,
6(2), 116-125. <a
href="http://dx.doi.org/10.1111/j.1743-7563.201
0.01286.x">[More Information]</a>
2009
Spillane, A., Noushi, F., Cooper, R., Gebski, V.,
Uren, R. (2009). High-resolution
lymphoscintigraphy is essential for recognition
of the significance of internal mammary nodes in
breast cancer. Annals of Oncology, 20(6),
977-984. <a
href="http://dx.doi.org/10.1093/annonc/mdn725"
>[More Information]</a>
Spillane, A., Brennan, M. (2009). Minimal
access breast surgery - A single breast incision
Publications for Andrew Spillane
for breast conservation surgery and sentinel
lymph node biopsy. European Journal of
Surgical Oncology, 35(4), 380-386. <a
href="http://dx.doi.org/10.1016/j.ejso.2008.07.00
9">[More Information]</a>
Karim, R., Gerega, S., Yang, J., Spillane, A.,
Carmalt, H., Scolyer, R., Lee, C. (2009).
Phyllodes tumours of the breast: a
clinicopathological analysis of 65 cases from a
single institution. The Breast, 18(3), 165-170. <a
href="http://dx.doi.org/10.1016/j.breast.2009.03.
001">[More Information]</a>
Spillane, A., Cheung, B., Stretch, J., Scolyer, R.,
Shannon, K., Quinn, M., Saw, R., McCarthy, W.,
Thompson, J. (2009). Proposed quality standards
for regional lymph node dissections in patients
with melanoma. Annals of Surgery, 249(3),
473-480. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
194d38f">[More Information]</a>
Karim, R., Gerega, S., Yang, J., Horvath, L.,
Spillane, A., Carmalt, H., Scolyer, R., Lee, C.
(2009). Proteins from the Wnt pathway are
involved in the pathogenesis and progression of
mammary phyllodes tumours. Journal of Clinical
Pathology, 62(11), 1016-1020. <a
href="http://dx.doi.org/10.1136/jcp.2009.066977
">[More Information]</a>
2008
Harrison, J., Choy, E., Spillane, A., Butow, P.,
Young, J., Evans, A. (2008). Australian breast
cancer specialists' involvement in
multidisciplinary treatment planning meetings.
The Breast, 17(4), 335-340. <a
href="http://dx.doi.org/10.1016/j.breast.2008.03.
001">[More Information]</a>
Spillane, A., Saw, R., Tucker, M., Byth Wilson,
K., Thompson, J. (2008). Defining lower limb
lymphedema after inguinal or ilio-inguinal
dissection in patients with melanoma using
classification and regression tree analysis. Annals
of Surgery, 248(2), 286-293. <a
href="http://dx.doi.org/10.1097/SLA.0b013e318
17ed7c3">[More Information]</a>
Moncrieff, M., Bowen, F., Thompson, J., Saw,
R., Shannon, K., Spillane, A., Quinn, M.,
Stretch, J. (2008). Keystone Flap Reconstruction
of Primary Melanoma Excision Defects of the
Leg-The End of the Skin Graft. Annals of
Surgical Oncology, 15(10), 2867-2873. <a
href="http://dx.doi.org/10.1245/s10434-008-001
8-8">[More Information]</a>
Shin, J., Spillane, A., Wills, E., Cooper, W.
(2008). PEComa of the retroperitoneum.
Pathology, 40(1), 93-95.
Brennan, M., Butow, P., Spillane, A. (2008).
Survivorship care after breast cancer. Australian
Family Physician, 37(10), 826-830. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19002302">[More Information]</a>
2007
Butow, P., Harrison, J., Choy, E., Young, J.,
Spillane, A., Evans, A. (2007). Health
professional and consumer views on involving
breast cancer patients in the multidisciplinary
discussion of their disease and treatment plan.
Cancer, 110(9), 1937-1944. <a
href="http://dx.doi.org/10.1002/cncr.23007">[M
ore Information]</a>
Brennan, M., Spillane, A. (2007). The evolving
role of the breast physician in the
multidisciplinary breast team. ANZ Journal of
Surgery, 77(10), 846-849. <a
href="http://dx.doi.org/10.1111/j.1445-2197.200
7.04255.x">[More Information]</a>
2006
Choy, E., Chiu, A., Butow, P., Young, J.,
Spillane, A. (2006). A pilot study to evaluate the
impact of involving breast cancer patients in the
multidisciplinary discussion of their disease and
treatment plan. The Breast, 16(2), 178-189.
Sanki, A., Spillane, A. (2006). Diagnostic and
treatment challenges of inframammary crease
breast carcinomas. ANZ Journal of Surgery,
76(4), 230-233. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16681539">[More Information]</a>
2005
Soni, N., Carmalt, H., Gillett, D., Spillane, A.
(2005). Evaluation of a breast cancer nomogram
for prediction of non-sentinel lymph node
positivity. European Journal of Surgical
Oncology, 31(9), 958-964. <a
href="http://dx.doi.org/10.1016/j.ejso.2005.04.01
1">[More Information]</a>
Soni, N., Spillane, A. (2005). Experience of
sentinel node biopsy alone in early breast cancer
without further axillary dissection in patients
with negative sentinel node. ANZ Journal of
Surgery, 75(5), 292-299. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15932439">[More Information]</a>
Hong, J., Chog, E., Soni, N., Carmalt, H., Gillett,
D., Spillane, A. (2005). Extra-axillary sentinel
node biopsy in the management of early breast
cancer. European Journal of Surgical Oncology,
31(9), 942-948. <a
href="http://dx.doi.org/10.1016/j.ejso.2005.08.00
3">[More Information]</a>
Nordman, I., Spillane, A., Hamilton, A. (2005).
Publications for Andrew Spillane
The aromatase inhibitors in early breast cancer:
who, when, and why? Medical Journal of
Australia, 183(1), 24-27. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15992333">[More Information]</a>
2004
Kim, J., Chung, D., Spillane, A. (2004).
Combined Radioguided Occult Lesion and
Sentinel Node Localization for Breast Cancer.
ANZ Journal of Surgery, 74, 550-553.
Spillane, A. (2004). Sentinel Node Biopsy in
Breast Cancer and Melanoma Requires Adequate
Self-Audit. ANZ Journal of Surgery, 74,
308-313.